Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow-to-Debt Ratio
Shandong Jincheng Pharmaceutical and Chemical Co Ltd cash flow-to-debt ratio. Shandong Jincheng Pharmaceutical and Chemical Co Ltd (300233) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of CN¥79.81 Million could theoretically repay 0% of its total liabilities (CN¥1.42 Billion) in one year. Check Shandong Jincheng Pharmaceutical and Che investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shandong Jincheng Pharmaceutical and Chemical Co Ltd (2008–2025)
Cash flow-to-debt ratio of Shandong Jincheng Pharmaceutical and Chemical Co Ltd from 2008 to 2025. Historical debt coverage capacity for Shandong Jincheng Pharmaceutical and Chemical Co Ltd across 18 annual periods. Check 300233 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Shandong Jincheng Pharmaceutical and Chemical Co Ltd Cash Flow-to-Debt Ratio by Year (2008–2025)
Shandong Jincheng Pharmaceutical and Chemical Co Ltd cash flow-to-debt ratio by year from 2008 to 2025. Year-by-year debt coverage analysis for Shandong Jincheng Pharmaceutical and Chemical Co Ltd. For the full cash flow conversion analysis, see Shandong Jincheng Pharmaceutical and Che (300233) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CN¥319.64 Million | CN¥1.47 Billion | ▲ +30.2% |
| 2024 | 0.17x | CN¥296.59 Million | CN¥1.77 Billion | ▼ -46.2% |
| 2023 | 0.31x | CN¥664.08 Million | CN¥2.14 Billion | ▲ +163.6% |
| 2022 | 0.12x | CN¥255.63 Million | CN¥2.17 Billion | ▼ -50.5% |
| 2021 | 0.24x | CN¥437.19 Million | CN¥1.84 Billion | ▼ -33.2% |
| 2020 | 0.36x | CN¥546.13 Million | CN¥1.53 Billion | ▼ -7.1% |
| 2019 | 0.38x | CN¥577.98 Million | CN¥1.51 Billion | ▲ +30.5% |
| 2018 | 0.29x | CN¥352.20 Million | CN¥1.20 Billion | ▲ +87.0% |
| 2017 | 0.16x | CN¥151.83 Million | CN¥966.24 Million | ▼ -51.0% |
| 2016 | 0.32x | CN¥241.48 Million | CN¥752.68 Million | ▲ +5.8% |
| 2015 | 0.30x | CN¥207.92 Million | CN¥685.95 Million | ▼ -7.7% |
| 2014 | 0.33x | CN¥219.46 Million | CN¥668.61 Million | ▲ +93.6% |
| 2013 | 0.17x | CN¥93.92 Million | CN¥554.11 Million | ▼ -3.3% |
| 2012 | 0.18x | CN¥86.61 Million | CN¥494.26 Million | ▲ +22.8% |
| 2011 | 0.14x | CN¥62.69 Million | CN¥439.36 Million | ▼ -23.5% |
| 2010 | 0.19x | CN¥108.67 Million | CN¥582.62 Million | ▼ -27.4% |
| 2009 | 0.26x | CN¥105.62 Million | CN¥411.04 Million | ▲ +248.2% |
| 2008 | 0.07x | CN¥30.23 Million | CN¥409.67 Million | — |